| Dec 31, 2021 | Dec 31, 2022 |
---|
Cash and cash equivalents | 130 | 71 |
---|
Marketable securities | 135 | 195 |
---|
Prepaid expenses | 10 | 14 |
---|
Receivables, Net, Current | 17 | 21 |
---|
Total current assets | 292 | 301 |
---|
Property, plant and equipment, net | 35 | 56 |
---|
Marketable securities | 97 | 1 |
---|
Intangible assets, net | 10 | 7 |
---|
Goodwill | 12 | 12 |
---|
Operating lease right-of-use assets | 276 | 241 |
---|
Restricted cash and other non-current assets | 39 | 38 |
---|
Total assets | 760 | 657 |
---|
Accounts payable | 6 | 7 |
---|
Accrued expenses and other current liabilities | 55 | 55 |
---|
Operating Lease, Liability, Current | 10 | 11 |
---|
Deferred revenue, current portion | 5 | 3 |
---|
Collaboration Research Advancement Current | 22 | 4 |
---|
Total current liabilities | 98 | 80 |
---|
Deferred revenue, net of current portion | 26 | 5 |
---|
Collaboration Research Advancement Non Current | 1 | - |
---|
Operating Lease, Liability, Noncurrent | 272 | 259 |
---|
Other non-current liabilities | 2 | 2 |
---|
Total liabilities | 400 | 346 |
---|
Common Stock, Value, Issued | 0 | 0 |
---|
Additional paid-in capital | 400 | 607 |
---|
Accumulated other comprehensive loss | -1 | -3 |
---|
Accumulated deficit | -39 | -294 |
---|
Total stockholders’ equity | 360 | 310 |
---|
Total liabilities and stockholders’ equity | 760 | 657 |
---|